Running clinical trials for new treatments of neurological conditions is becoming more and more challenging: it is difficult to recruit patients, monitor them in a quantitative manner, and over the long period of time that these clinical trials last. Mon4t’s platform offers a holistic solution to address these challenges:

First, an inclusive screening protocol supports patient selection, which increases the likelihood for enrolling suitable candidates. Then, a quantitative assessment of motor and cognitive symptoms reduces inter and intra rater variability. Tests are performed using the participants’ smartphone as a medical device, which enables decentralized clinical trials that may last several years. Furthermore, Mon4t’s platform can provide a readily available reference data for patients as well as healthy controls. Altogether, Mon4t improves outcome quality and reduces time-to-market.